- Under new April 2020 FDA guidance [1], the Avalon CL Fetal and Maternal Pod and Patch are now available in the U.S., in addition to existing countries in Europe, Australia, New Zealand and Singapore, to support fetal and maternal monitoring
- Integrated with Philips’ comprehensive obstetrical care portfolio, the new offering has the potential to reduce mother and clinician risk of exposure to COVID-19, in hospital and in the home
- Solution complements Philips innovative Remote Patient Monitoring suite designed to transform care for at-risk populations